Are you Dr. King?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 66 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4800 Riverbend Rd
Suite 200
Boulder, CO 80301Phone+1 303-415-8850Fax+1 303-415-8870
Summary
- Dr. Mark King, MD is an infectious disease specialist in Boulder, Colorado. He is currently licensed to practice medicine in Colorado, Georgia, and California. He is affiliated with Boulder Community Health.
Education & Training
- Emory University School of MedicineFellowship, Infectious Disease, 1998 - 2001
- Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 1994 - 1997
- McGovern Medical School at UTHealthClass of 1994
Certifications & Licensure
- CA State Medical License 1995 - Present
- CO State Medical License 2004 - 2025
- GA State Medical License 1998 - 2005
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PrimeSUITE EHR, Greenway Health, LLC, 2011-2012
Clinical Trials
- The Impact of an Antimicrobial Utilization Program on Antimicrobial Use Start of enrollment: 2002 Oct 01
Publications & Presentations
PubMed
- 98 citationsImpact of an antimicrobial utilization program on antimicrobial use at a large teaching hospital: a randomized controlled trial.Bernard C. Camins, Mark D. King, Jane B. Wells, Heidi L. Googe, Manish Patel
Infection Control and Hospital Epidemiology. 2009-10-01 - 1 citationsA multicenter study on optimizing piperacillin-tazobactam use: lessons on why interventions fail.Robert P. Gaynes, Carolyn V. Gould, Jonathan R. Edwards, Theresa L. Antoine, Henry M. Blumberg
Infection Control and Hospital Epidemiology. 2009-06-16 - 11 citationsKnowledge, Attitudes, and Behaviors Regarding Piperacillin‐Tazobactam Prescribing Practices: Results From a Multicenter StudyTheresa L. Antoine, Amy B. Curtis, Henry M. Blumberg, Kathryn DeSilva, Mesfin Fransua
Infection Control and Hospital Epidemiology. 2006-10-23